FDA Inspection 1260001 — Biomat USA Inc
The FDA completed an inspection of Biomat USA Inc on January 30, 2025 in Reno, NV. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 30, 2025
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Reno, NV (United States)